Experiment Accession	Tissue	Cell Line	Description	Disease	PubMed ID	Article Title	Sex	Experiment Title	Study Title	Instrument	Submitter	Study Accession	Sample Accession	Total Size, Mb	Total RUNs	Total Bases
DRX003170	Lung		Adenocarcinoma with bone metastasis	Cancer	23593434	Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing.		microRNAs sequence with bone metastasis	Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing	Illumina HiSeq 2000	Tumor Hospital of Yunnan Province	DRP000950	DRS003336	297.73	1	471061500
DRX003171	Lung		Adenocarcinoma without bone metastasis	Cancer	23593434	Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing.		microRNAs sequence without bone metastasis	Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing	Illumina HiSeq 2000	Tumor Hospital of Yunnan Province	DRP000950	DRS003337	343.45	1	536562446
DRX005946	Saliva		Salivary exosome I	Normal	23302638	Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.		Small RNA Transcriptomes of human salivary exosome I	Small RNA Transcriptomes of Two Types of Exosomes in Human Whole Salivadetermined by Next Generation Sequencing	Illumina Genome Analyzer IIx	TEIKYO_HEISEI	DRP000998	DRS005865	529.3	1	1096749441
DRX005947	Saliva		Salivary exosome II	Normal	23302638	Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.		Small RNA Transcriptomes of human salivary exosome II	Small RNA Transcriptomes of Two Types of Exosomes in Human Whole Salivadetermined by Next Generation Sequencing	Illumina Genome Analyzer IIx	TEIKYO_HEISEI	DRP000998	DRS005866	470.62	1	941529921
DRX005948	Saliva		Whole Saliva	Normal	23302638	Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.		Small RNA Transcriptomes of human whole saliva	Small RNA Transcriptomes of Two Types of Exosomes in Human Whole Salivadetermined by Next Generation Sequencing	Illumina Genome Analyzer IIx	TEIKYO_HEISEI	DRP000998	DRS005867	488.72	1	961163952
DRX011925	Bladder		Sample#1_normal bladder epithelia	Normal	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.		Sample#1_normal bladder epithelia	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011767	536.67	1	803501706
DRX011926	Bladder		Sample#2_normal bladder epithelia	Normal	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.		Sample#2_normal bladder epithelia	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011768	566.26	1	850264317
DRX011927	Bladder		Sample#3_normal bladder epithelia	Normal	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.		Sample#3_normal bladder epithelia	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011769	561.72	1	848104887
DRX011928	Bladder		Sample#4_normal bladder epithelia	Normal	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.		Sample#4_normal bladder epithelia	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011770	560.64	1	844542489
DRX011929	Bladder		Sample#5_normal bladder epithelia	Normal	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.		Sample#5_normal bladder epithelia	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011771	611.95	1	928003944
DRX011930	Bladder		Sample#6_bladder cancer_UC_G3_pT2_65yo_male	Bladder cancer	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.	Male	Sample#6_bladder cancer_UC_G3_pT2_65yo_male	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011772	516.88	1	775099591
DRX011931	Bladder		Sample#7_bladder cancer_UC>SCC_G3_pT3_76yo_male	Bladder cancer	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.	Male	Sample#7_bladder cancer_UC>SCC_G3_pT3_76yo_male	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011773	492.6	1	730761647
DRX011932	Bladder		Sample#8_bladder cancer_UC_G2_pT2_91yo_male	Bladder cancer	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.	Male	Sample#8_bladder cancer_UC_G2_pT2_91yo_male	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011774	478.2	1	688277324
DRX011933	Bladder		Sample#9_bladder cancer_UC_G2_pT2_92yo_female	Bladder cancer	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.	Female	Sample#9_bladder cancer_UC_G2_pT2_92yo_female	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011775	494.1	1	705671344
DRX011934	Bladder		Sample#10_bladder cancer_UC_G3_pT2_83yo_male	Bladder cancer	24520312	The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.	Male	Sample#10_bladder cancer_UC_G3_pT2_83yo_male	The microRNA expression signature of bladder cancer assessed by deep sequencing	Illumina HiSeq 2000	KAGOSHIMA	DRP001085	DRS011776	475.65	1	681351076
DRX012360	Blood		CD19+ B Cells, donor1		24670764	A promoter-level mammalian expression atlas.		11544-120B5_SRhi10066.TAGCTT	A promoter level mammalian expression atlas (human, sRNA-Seq)	Illumina HiSeq 2000	RIKEN_OSC	DRP001151	DRS012097	374.12	1	532455198
DRX012361	Blood		CD19+ B Cells, donor2		24670764	A promoter-level mammalian expression atlas.		11624-122B4_SRhi10066.GGCTAC	A promoter level mammalian expression atlas (human, sRNA-Seq)	Illumina HiSeq 2000	RIKEN_OSC	DRP001151	DRS012098	348.13	1	496954404
DRX012362	Blood		CD19+ B Cells, donor3		24670764	A promoter-level mammalian expression atlas.		11705-123B4_SRhi10066.CTTGTA	A promoter level mammalian expression atlas (human, sRNA-Seq)	Illumina HiSeq 2000	RIKEN_OSC	DRP001151	DRS012099	506.16	1	722691267
DRX017208		MCF7	MCF-7 Negative control 4	Breast cancer	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017433	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002326	DRS016242	1536.55	1	2193536112
DRX017209		MCF7	MCF-7 Negative control 5	Breast cancer	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017434	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002326	DRS016243	1703.27	1	2426097846
DRX017210		MCF7	MCF-7 PAPD5 overexpressed 4	Breast cancer	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017435	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002326	DRS016244	1289.01	1	1827911247
DRX017211		MCF7	MCF-7 PAPD5 overexpressed 5	Breast cancer	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017436	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002326	DRS016245	1355.58	1	1920648678
DRX017212		MCF7	MCF-7 Negative control	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017437	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002333	DRS016321	2314.03	1	3297340638
DRX017213		MCF7	MCF-7 PAPD5 overexpressed	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017438	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002333	DRS016322	2606.01	1	3733440924
DRX017214		THP1	THP-1 Negative control	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017439	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002333	DRS016323	896.97	1	1322185608
DRX017215		THP1	THP-1 PAPD5 overexpressed	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017440	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002333	DRS016324	1603.93	1	2362014459
DRX017216		THP1	CNOT6L-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017441	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016363	655.64	1	974640549
DRX017217		THP1	ERI1-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017443	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016364	513.73	1	767906847
DRX017218		THP1	EXOSC10-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017445	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016365	786.28	1	1164085353
DRX017219		THP1	EXOSC4-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017446	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016366	661.52	1	987511062
DRX017220		THP1	NC-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017447	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016367	683.1	1	1034087067
DRX017221		THP1	PAN3-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017450	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016368	539.2	1	801562410
DRX017222		THP1	PARN-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017453	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016369	745.99	1	1114624890
DRX017223		THP1	RNASEL-1	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017455	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002337	DRS016370	547.5	1	821168799
DRX017224		THP1	CNOT6L-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017442	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016273	622.5	1	927878037
DRX017225		THP1	ERI1-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017444	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016274	659.04	1	983017503
DRX017226		THP1	NC-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017448	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016275	1085.62	1	1670437476
DRX017227		THP1	NC_Ando	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017449	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016276	709.5	1	1050534669
DRX017228		THP1	PAN3-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017451	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016277	531.18	1	796474395
DRX017229		THP1	PAPD5_Ando	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017452	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016278	639.85	1	961392687
DRX017230		THP1	PARN-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017454	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016279	619.35	1	931564674
DRX017231		THP1	RNASEL-2	Acute monocytic leukemia	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Male	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017456	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002328	DRS016280	649.36	1	967160124
DRX017232		MCF7	KD control, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017457	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016297	668.51	1	1088935782
DRX017233		MCF7	KD control, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017458	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016298	596	1	979264974
DRX017234		MCF7	NC, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017460	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016299	480.37	1	761579940
DRX017235		MCF7	NC, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017461	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016300	552.35	1	875764707
DRX017236		MCF7	OE control + PARN KD, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017463	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016301	432.29	1	676225371
DRX017237		MCF7	OE control, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017466	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016302	387.18	1	626705748
DRX017238		MCF7	PAPD5 OE + PARN KD, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017469	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016303	367.06	1	574758576
DRX017239		MCF7	PAPD5 OE + PARN control, repl. 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017472	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016304	518.15	1	855404181
DRX017240		MCF7	PAPD5 OE, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017475	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016305	283.05	1	453877560
DRX017241		MCF7	PAPD5 OE, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017476	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016306	444.38	1	719289006
DRX017242		MCF7	PARN KD, replicate 1	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017478	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016307	341.39	1	538454889
DRX017243		MCF7	PARN KD, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017479	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002331	DRS016308	378.69	1	599824056
DRX017353		MCF7	KD control, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017459	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016309	595.44	1	958224618
DRX017354		MCF7	NC, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017462	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016310	412.49	1	658866909
DRX017355		MCF7	OE control + PARN KD, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017464	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016311	444.31	1	697079169
DRX017356		MCF7	OE control + PARN KD, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017465	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016312	372.11	1	580333335
DRX017357		MCF7	OE control, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017467	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016313	374.44	1	599083179
DRX017358		MCF7	OE control, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017468	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016314	296.85	1	472959771
DRX017359		MCF7	PAPD5 OE + PARN KD, replicate 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017470	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016315	531.32	1	831888030
DRX017360		MCF7	PAPD5 OE + PARN KD, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017471	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016316	548.98	1	852646458
DRX017361		MCF7	PAPD5 OE + PARN control, repl. 2	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017473	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016317	739.8	1	1189465809
DRX017362		MCF7	PAPD5 OE + PARN control, repl. 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017474	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016318	614.54	1	991620999
DRX017363		MCF7	PAPD5 OE, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017477	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016319	339.78	1	545158278
DRX017364		MCF7	PARN KD, replicate 3	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina HiSeq 2000 sequencing of SAMD00017480	PAPD5-mediated adenylation of miR-21	Illumina HiSeq 2000	RIKEN_CLST_DGT	DRP002332	DRS016320	395.09	1	612863736
DRX017378		MCF7	0 hour after estrogen treatment	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina Genome Analyzer sequencing of SAMD00017425	PAPD5-mediated adenylation of miR-21	Illumina Genome Analyzer	RIKEN_CLST_DGT	DRP002330	DRS016289	24.63	1	34337340
DRX017386		MCF7	0 hour after estrogen treatment	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina Genome Analyzer sequencing of SAMD00017425	PAPD5-mediated adenylation of miR-21	Illumina Genome Analyzer	RIKEN_CLST_DGT	DRP002330	DRS016289	26.73	1	37363716
DRX017394		MCF7	6 hours after estrogen treatment	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina Genome Analyzer sequencing of SAMD00017429	PAPD5-mediated adenylation of miR-21	Illumina Genome Analyzer	RIKEN_CLST_DGT	DRP002330	DRS016293	20.63	1	29710404
DRX017402		MCF7	6 hours after estrogen treatment	Adenocarcinoma	25049417	PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.	Female	Exp Accession: Illumina Genome Analyzer sequencing of SAMD00017429	PAPD5-mediated adenylation of miR-21	Illumina Genome Analyzer	RIKEN_CLST_DGT	DRP002330	DRS016293	30.13	1	42107436
ERX344793		HeLa-S3	HeLaS3_rep1		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371265	2912.17	1	4656649150
ERX344794		HeLa-S3	HeLaS3_rep1		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371265	2408.78	1	4282445450
ERX344795		HeLa-S3	HeLaS3_rep2		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371266	1591.7	1	2934871250
ERX344796		HeLa-S3	HeLaS3_rep1		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371265	1251.34	1	2057772050
ERX344797		HeLa-S3	HeLaS3_rep2		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371266	1618.49	1	3208618900
ERX344798		HeLa-S3	HeLaS3_rep2		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago2-bound short RNAs in HeLaS3 cell line	Ago2-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	La Sapienza University of Rome	ERP004329	ERS371266	1338.96	1	2338426300
ERX350059		HeLa-S3	HeLaS3		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago1-bound short RNAs in HeLaS3 cell line	Ago1-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	Sapienza Universita di Roma	ERP004389	ERS374062	4585.73	1	6840107450
ERX350060		HeLa-S3	HeLaS3		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago1-bound short RNAs in HeLaS3 cell line	Ago1-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	Sapienza Universita di Roma	ERP004389	ERS374062	7503.37	1	11765949400
ERX350061		HeLa-S3	HeLaS3		25605800	ARGONAUTE2 cooperates with SWI/SNF complex to determine nucleosome occupancy at human Transcription Start Sites.		Ago1-bound short RNAs in HeLaS3 cell line	Ago1-bound short RNAs in HeLaS3 cell line	Illumina HiSeq 2000	Sapienza Universita di Roma	ERP004389	ERS374062	4733.01	1	7235814300
ERX358440	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	986.31	1	1660919459
ERX358441	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	991.5	1	1660919459
ERX358442	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1047.36	1	1732518537
ERX358443	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1053.02	1	1732518537
ERX358444	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1007.51	1	1677057535
ERX358445	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1016.54	1	1677057535
ERX358446	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1036.55	1	1726760299
ERX358447	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1048.93	1	1726760299
ERX358448	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1020.41	1	1701259190
ERX358449	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	1034.99	1	1701259190
ERX358450	Hair follicle		Dermal papilla		24582062	A role of placental growth factor in hair growth.			sequencing of hair dermal papilla	Illumina Genome Analyzer IIx	SNU	ERP004469	ERS384432	930.59	1	1582751932
SRX197301		HKCI-4	HKCI-4 liver cancer cell		23376363	Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.		HKCI-4 small non-coding RNA sequencing	HKCI cancer cell lines small ncRNA study	Illumina HiSeq 2000	The Chinese University of Hong Kong	SRP016516	SRS369357	278.6	1	321214212
SRX197302		HKCI-8	HKCI-8 liver cancer cell		23376363	Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.		HKCI-8 small noncoding RNA sample	HKCI cancer cell lines small ncRNA study	Illumina HiSeq 2000	The Chinese University of Hong Kong	SRP016516	SRS370726	291.71	1	334259208
SRX197303		MIHA	MIHA immortalized liver cell line		23376363	Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.		MIHA small noncoding RNA	HKCI cancer cell lines small ncRNA study	Illumina HiSeq 2000	The Chinese University of Hong Kong	SRP016516	SRS370727	416.21	1	398286853
SRX201519		HepG2	human HCC cell line		23359607	Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines.		sRNA-Seq of HepG2	Small RNA Sequencing of doxorubicin-resistant and parental human hepatocellular carcinoma cell lines	Illumina HiSeq 2000	Shenzhen-PKU-HKUST Medical Center	SRP016817	SRS373086	451.27	1	694017968
SRX201588		HepG2	DOX-resistant counterpart of HCC cell line (HepG2/DOX)		23359607	Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines.		sRNA-Seq of GepG2_ADM	Small RNA Sequencing of doxorubicin-resistant and parental human hepatocellular carcinoma cell lines	Illumina HiSeq 2000	Shenzhen-PKU-HKUST Medical Center	SRP016817	SRS373087	489.57	1	718041933
SRX262174	Plasma		mother_trio_1	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_1	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS402752	47.47	1	53138268
SRX262175	Plasma		mother_trio_2	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_2	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409117	30.48	1	33674184
SRX262176	Plasma		mother_trio_3	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_3	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409118	22.78	1	25678692
SRX262177	Plasma		mother_trio_6	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_6	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409119	282.41	1	380817408
SRX262178	Plasma		mother_trio_8	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_8	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409120	120.85	1	161032806
SRX262179	Plasma		mother_trio_10	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_10	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409121	159.13	1	210229956
SRX262180	Plasma		mother_trio_12	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	mother_trio_12	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409122	33.1	1	44121681
SRX262181	Plasma		umbilical_trio_1	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_1	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409123	44.12	1	49325832
SRX262182	Plasma		umbilical_trio_2	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_2	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409124	18.49	1	20778156
SRX262183	Plasma		umbilical_trio_3	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_3	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409125	40.85	1	45878688
SRX262184	Plasma		umbilical_trio_4	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_4	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409126	51.91	1	58470732
SRX262185	Plasma		umbilical_trio_6	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_6	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409127	417.18	1	593075583
SRX262186	Plasma		umbilical_trio_7	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_7	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409128	284.79	1	434274741
SRX262187	Plasma		umbilical_trio_8	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_8	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409129	510.36	1	681354696
SRX262188	Plasma		umbilical_trio_10	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_10	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409130	167.97	1	227442915
SRX262189	Plasma		umbilical_trio_11	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_11	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409131	78.01	1	115920858
SRX262190	Plasma		umbilical_trio_12	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	umbilical_trio_12	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409132	142.9	1	190434051
SRX262191	Plasma		father_trio_1	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Male	father_trio_1	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409133	34.89	1	40420584
SRX262192	Plasma		father_trio_6	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Male	father_trio_6	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409134	82.17	1	111347280
SRX262193	Plasma		father_trio_8	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Male	father_trio_8	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409135	116.86	1	156933171
SRX262194	Plasma		father_trio_10	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Male	father_trio_10	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409136	190.07	1	253772481
SRX262195	Plasma		father_trio_12	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Male	father_trio_12	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409137	57.73	1	76213890
SRX262196	Placenta		placenta_trio_5	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_5	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409138	97.89	1	142359666
SRX262197	Placenta		placenta_trio_6	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_6	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409139	95.64	1	137103096
SRX262198	Placenta		placenta_trio_7	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_7	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409140	236.78	1	341960559
SRX262199	Placenta		placenta_trio_8	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_8	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409141	80.88	1	116639142
SRX262200	Placenta		placenta_trio_9	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_9	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409142	79.96	1	113104230
SRX262201	Placenta		placenta_trio_10	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_10	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409143	175.58	1	252403386
SRX262202	Placenta		placenta_trio_11	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_11	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409144	132.81	1	185877864
SRX262203	Placenta		placenta_trio_12	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	not_documented	placenta_trio_12	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409145	144.91	1	210091797
SRX262204	Plasma		non_pregnant_1	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	non_pregnant_1	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409146	155.97	1	210119847
SRX262205	Plasma		non_pregnant_2	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	non_pregnant_2	circulating miRNA	Illumina Genome Analyzer II	The Rockefeller University	SRP018255	SRS409147	7.5	1	8148564
SRX262206	Serum		non_pregnant_3	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	non_pregnant_3	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409148	79.82	1	104693106
SRX262207	Serum		non_pregnant_4	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	non_pregnant_4	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409149	50.9	1	66747168
SRX262208	Serum		non_pregnant_5	Normal	23440203	Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.	Female	non_pregnant_5	circulating miRNA	Illumina HiSeq 2000	The Rockefeller University	SRP018255	SRS409150	49.61	1	65869203
SRX271415	Testis		1206014_AM7972, purchased from Ambion		24981367	A comprehensive analysis of piRNAs from adult human testis and their relationship with genes and mobile elements.	Male	The human piRNA sequencing	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	RUTGERS	SRP021475	SRS415822	214.86	1	342277200
SRX271416	Testis		OD36264-18 , obtained from NDRI		24981367	A comprehensive analysis of piRNAs from adult human testis and their relationship with genes and mobile elements.	Male	The human piRNA sequencing-1	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	RUTGERS	SRP021475	SRS415823	761.73	1	1145382900
SRX271417	Testis		1203013_AM7972, purchased from Ambion		24981367	A comprehensive analysis of piRNAs from adult human testis and their relationship with genes and mobile elements.	Male	The human piRNA sequencing-2	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	RUTGERS	SRP021475	SRS415824	838.91	1	1264801200
SRX273661		AU565	Breast cancer cell line		24116077	Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines.		Rawdata Au565	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	University of Tromsoe	SRP022047	SRS418081	1563.09	2	2509986800
SRX273666		SKBR3	Breast cancer cell line		24116077	Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines.		Rawdata SkBr3_Illumina	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	University of Tromsoe	SRP022047	SRS418084	1810.49	2	2940925700
SRX273668		Hs-578Bst	Breast cancer cell line		24116077	Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines.		Rawsequences Hs578Bst	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	University of Tromsoe	SRP022047	SRS418086	392.78	1	576784776
SRX290576	Pancreas		Islets of Langerhans (Isl1)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Male	human pancreatic islet miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina Genome Analyzer IIx	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431738	570.24	1	904152990
SRX290601	Pancreas		Islets of Langerhans (Isl2)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Female	human pancreatic islet miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina Genome Analyzer IIx	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431763	171.66	1	281739504
SRX290617	Pancreas		Islets of Langerhans (Isl3)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Female	human pancreatic islet miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina HiSeq 2000	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431779	3124.68	1	4070828874
SRX290620	Pancreas		Beta-cells (Beta1)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Male	human pancreatic beta-cell miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina Genome Analyzer IIx	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431782	169.54	1	244093191
SRX290623	Pancreas		Beta-cells (Beta2)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Female	human pancreatic beta-cell miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina HiSeq 2000	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431785	1783.1	1	2116348020
SRX290626	Pancreas		Beta-cells (Beta3)		23372846	The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.	Female	human pancreatic beta-cell miRNA sequencing	miRNA-sequencing of human pancreatic whole islets and enriched beta-cells	Illumina HiSeq 2000	Oxford Centre for Diabetes, Endocrinology & Metabo	SRP023531	SRS431788	1432.38	1	1694916048
SRX318164	Blood		Peripheral blood mononuclear cells (osteopetrosis_Ou)	Osteopetrosis	24084574	Identification of potential microRNA-target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics.		MicroRNA profile of peripheral blood mononuclear cells from osteopetrosis patients	MicroRNA profiling	Illumina HiSeq 2000	Chongqing Medical University	SRP026558	SRS455099	320.21	1	520788562
SRX318180	Blood		Peripheral blood mononuclear cells (Control_Ou)	Normal	24084574	Identification of potential microRNA-target pairs associated with osteopetrosis by deep sequencing, iTRAQ proteomics and bioinformatics.		MicroRNA profile of peripheral blood mononuclear cells from controls	MicroRNA profiling	Illumina HiSeq 2000	Chongqing Medical University	SRP026558	SRS455116	312.74	1	503703536
SRX327157		iMSC	IMSC#3, 0 hrs adipocyte differentiation		24857590	Generation and characterization of an immortalized human mesenchymal stromal cell line.	Male	iMSC#3 adipogenic differentiation miRNA-iMSC#3_0h	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	Oslo University Hospital	SRP028157	SRS463542	13.49	1	26028867
SRX332339		SH-SY5Y	Control 1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Control 1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469885	921.55	1	1455686150
SRX333113		iMSC	IMSC#3, 7 days adipocyte differentiation		24857590	Generation and characterization of an immortalized human mesenchymal stromal cell line.	Male	iMSC#3_7d	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	Oslo University Hospital	SRP028157	SRS468504	16.17	1	32650838
SRX333114		iMSC	IMSC#3, 14 days adipocyte differentiation		24857590	Generation and characterization of an immortalized human mesenchymal stromal cell line.	Male	iMSC#3_14d	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	Oslo University Hospital	SRP028157	SRS468505	19.78	1	38966636
SRX333115		iMSC	IMSC#3, 21 days adipocyte differentiation		24857590	Generation and characterization of an immortalized human mesenchymal stromal cell line.	Male	iMSC#3_21d	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	Oslo University Hospital	SRP028157	SRS468506	15.87	1	31429788
SRX334991		SH-SY5Y	DGCR8 kd, rep1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		DGCR8 kd, rep1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469886	1878.04	1	3015868300
SRX334992		SH-SY5Y	DGCR8 kd, rep2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		DGCR8 kd, rep2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469887	1880.23	1	3023687300
SRX334993		SH-SY5Y	Drosha kd, rep1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Drosha kd, rep1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469888	3493.93	1	5672967100
SRX334994		SH-SY5Y	Drosha kd, rep2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Drosha kd, rep2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469889	3502.57	1	5698079800
SRX334995		SH-SY5Y	Control 2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Control 2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469890	2101.65	1	3388539100
SRX334996		SH-SY5Y	Dicer kd		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Dicer kd	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469891	2655.66	1	4435560900
SRX334997		SH-SY5Y	Ago2 kd		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Ago2 kd	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469892	2742.92	1	4370592150
SRX334998		SH-SY5Y	Differentiated, part 1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Differentiated, part 1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469893	547.38	1	1152150800
SRX334999		SH-SY5Y	Differentiated, part 2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Differentiated, part 2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469894	1140.62	1	1920557650
SRX335000		SH-SY5Y	Undifferentiated, part 1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Undifferentiated, part 1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469895	967.34	1	1588212750
SRX335001		SH-SY5Y	Undifferentiated, part 2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Undifferentiated, part 2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469896	828.9	1	1496840900
SRX335002		SH-SY5Y	Differentiated capture, part 1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Differentiated capture, part 1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469897	323.93	1	528070550
SRX335003		SH-SY5Y	Differentiated capture, part 2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Differentiated capture, part 2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469898	2250.13	1	3731365400
SRX335004		SH-SY5Y	Undifferentiated capture, part 1		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Undifferentiated capture, part 1	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469899	1130.58	1	1844870700
SRX335005		SH-SY5Y	Undifferentiated capture, part 2		24708865	Evidence for the biogenesis of more than 1,000 novel human microRNAs.		Undifferentiated capture, part 2	Homo sapiens strain:SH-SY5Y neuroblastoma cellsTranscriptome or Gene expression	Illumina HiSeq 2000	CRG	SRP028574	SRS469900	251.98	1	410905000
SRX341093		143B	Untransfected control mito-RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial RNA  mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	213.02	1	422292920
SRX341106		143B	Untransfected control mito-RNA treated with RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial RNA treated with RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	126.36	1	230744920
SRX341144		143B	Untransfected control mito-RNA treated RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial RNA treated RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	196.73	1	416767785
SRX341145		143B	Untransfected control mito-RNA treated RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial RNA treated RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	196.43	1	358932035
SRX341166		143B	Chloramphenicol treated 143B mito-RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		chloramphenicol treated 143B mitochondrial RNA mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	109.15	1	255098655
SRX341167		143B	Chloramphenicol treated 143B mito-RNA treated RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		chloramphenicol treated 143B mitochondrial RNA treated RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	35.08	1	63965020
SRX341168		143B	Chloramphenicol treated 143B mito-RNA treated RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		chloramphenicol treated 143B mitochondrial RNA treated RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	97.08	1	222996165
SRX341170		143B	Chloramphenicol treated 143B mito-RNA treated RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		chloramphenicol treated 143B mitochondrial RNA treated RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	139.23	1	248165155
SRX341182		143B	Treated with non-targeted control siRNAs mito-RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with non-targeted control siRNAs mitochondrial RNA  mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	92.15	1	219455320
SRX341183		143B	Treated with non-targeted control siRNAs mito-RNA treated RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with non-targeted control siRNAs mitochondrial RNA treated RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	61.17	1	112148190
SRX341184		143B	Treated with non-targeted control siRNAs mito-RNA treated RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with non-targeted control siRNAs mitochondrial RNA treated RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	108.62	1	234452225
SRX341185		143B	Treated with non-targeted control siRNAs mito-RNA treated RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with non-targeted control siRNAs mitochondrial RNA treated RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	139.76	1	250144650
SRX341926		143B	Untransfected control mitochondrial purified RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial purified RNA  mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	100.98	1	235829580
SRX341928		143B	Untransfected control mitochondrial purified RNA treated with RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial purified RNA treated with RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	73.09	1	136013080
SRX341931		143B	Untransfected control mitochondrial purified RNA treated with RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial purified RNA treated with RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	175.52	1	359950955
SRX341933		143B	Untransfected control mitochondrial purified RNA treated with RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B untransfected control mitochondrial purified RNA treated with RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	236.17	1	420998130
SRX344776		IBL_LCLd3	EBV+ lymphoblastoid cell line		24257599	Evolutionary conservation of primate lymphocryptovirus microRNA targets.		EBV and rLCV miRNA-SEQ and PAR-CLIP	miRNA-SEQ and PAR-CLIP analyis of EBV+ and rLCV+ LCLs	Illumina HiSeq 2000	Duke University	SRP029579	SRS476612	1323.64	2	2334916400
SRX345905	Nasopharynx		FFPE-NPC3	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC FFPE Tissue 3	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477175	176.26	1	290812860
SRX345906	Nasopharynx		FFPE-Ctrl1		24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC FFPE Ctrl Tissue 1	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477176	179.82	1	293824332
SRX345908	Nasopharynx		FFPE-Ctrl2		24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC FFPE Ctrl Tissue 2	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477179	179.19	1	293502780
SRX345909	Serum		Sera-MalayCtrl		24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC serum control pool	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477180	170.33	1	292310028
SRX345910	Serum		Sera-MalayLow	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC serum from Malaysia (low VCA titer)	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477187	231.71	1	400925052
SRX345913	Serum		Sera-MalayMid	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC Malaysia serum (Mid VCA titer)	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477183	114.36	1	199100124
SRX345915	Serum		Sera-MalayHigh	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC Malaysia serum (High VCA titer)	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477181	222.89	1	391818528
SRX345916	Nasopharynx		FFPE-NPC1	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC FFPE Tissue 1	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477184	138.04	1	226683000
SRX345917	Nasopharynx		FFPE-NPC2	Nasopharyngeal carcinoma	24393330	Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.		Small RNA-sequencing of NPC FFPE Tissue 2	Homo sapiens Transcriptome or Gene expression	Illumina Genome Analyzer IIx	The George Washington University	SRP029599	SRS477185	136.74	1	223655328
SRX349068	Serum		Patient infected TB	Tuberculosis	24349033	Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.		MicroRNA_Case for human	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Zhejiang University	SRP029907	SRS479660	787.23	1	1175966141
SRX349069	Serum		Control	Normal	24349033	Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.		MicroRNA_Control for human	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Zhejiang University	SRP029907	SRS479660	740.45	1	1123582299
SRX349101	Plasma		CFS1	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	CFS-plasma_miRNA	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS481324	4419.57	1	7749460250
SRX349967		143B	Treated with MRPP1 siRNAs mitochondrial RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with MRPP1 siRNAs mitochondrial RNA mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	122.05	1	277670190
SRX349968		143B	Treated with MRPP1 siRNAs mitochondrial RNA RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with MRPP1 siRNAs mitochondrial RNA RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	57.15	1	102429285
SRX349969		143B	Treated with MRPP1 siRNAs mitochondrial RNA RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with MRPP1 siRNAs mitochondrial RNA RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	110.06	1	222650925
SRX349970		143B	Treated with MRPP1 siRNAs mitochondrial RNA RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with MRPP1 siRNAs mitochondrial RNA RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	143.64	1	253944320
SRX350126		143B	Treated with PTCD1 siRNAs mitochondrial RNA mock		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with PTCD1 siRNAs mitochondrial RNA mock	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	108.92	1	246361920
SRX350127		143B	Treated with PTCD1 siRNAs mitochondrial RNA RNase A		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with PTCD1 siRNAs mitochondrial RNA RNase A	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	33.28	1	61307820
SRX350128		143B	Treated with PTCD1 siRNAs mitochondrial RNA RNase T1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with PTCD1 siRNAs mitochondrial RNA RNase T1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	108.69	1	221147500
SRX350129		143B	Treated with PTCD1 siRNAs mitochondrial RNA RNase V1		24183674	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting.		143B cells treated with PTCD1 siRNAs mitochondrial RNA RNase V1	Mapping of mitochondrial RNA-protein interactions by digital RNase footprinting	Illumina Genome Analyzer II	Institute for Molecular Bioscience UQ	SRP029306	SRS474355	134.07	1	240033780
SRX352359	Plasma		CFS1	Chronic fatigue syndrome	25238588		Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS481324	372.22	1	633916300
SRX353113	Liver		Cirrhotic liver	Liver cirrhosis	24009312	Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia.		Cirrhotic liver miRNA	Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia	Illumina HiSeq 2000	Albert Einstein College of Medicine	SRP030022	SRS481826	1839.18	1	2829533800
SRX360406		Akata_LCLd3	EBV+ lymphoblastoid cell line		24257599	Evolutionary conservation of primate lymphocryptovirus microRNA targets.		AkataLCLd3	miRNA-SEQ and PAR-CLIP analyis of EBV+ and rLCV+ LCLs	Illumina HiSeq 2000	Duke University	SRP029579	SRS487857	892.03	1	1482288300
SRX362352	Plasma		CFS2	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489176	369.34	1	651191100
SRX362353	Plasma		CFS3	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489178	360.77	1	665242250
SRX362354	Plasma		CFS4	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489179	402.24	1	703883300
SRX362355	Plasma		CFS5	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489180	331.93	1	590474300
SRX362356	Plasma		CFS6	Chronic fatigue syndrome	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489181	402.61	1	693217150
SRX362357	Plasma		NF1	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489182	363.15	1	647371800
SRX362358	Plasma		NF2	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489183	383.69	1	654212650
SRX362359	Plasma		NF3	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489184	361.82	1	615054550
SRX362360	Plasma		NF4	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489185	363.58	1	640916900
SRX362361	Plasma		NF5	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489186	360.73	1	639491450
SRX362362	Plasma		NF6	Non-fatigued	25238588	High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.	Female	High-Throughput Sequencing of Plasma miRNA in CFS	Homo sapiens Transcriptome or Gene expression	Illumina HiSeq 2000	Bond University	SRP029994	SRS489187	347.59	1	614488500
SRX362363		NPC-CNE-2	NPC Cell line CNE-2		24367666	Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing.		CNE-2 small RNA sequencing	human NPC cell line CNE-2 Transcriptome or Gene expression	Illumina HiSeq 2000	Department  of  Otolaryngology,  Xiangya  Hospital	SRP030673	SRS489189	381.81	1	591838660
SRX362364		NPC-CNE-2	NPC Cell line CNE-2 with radio-resistance		24367666	Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing.		CNE-2-Rs small RNA sequencing	human NPC cell line CNE-2 Transcriptome or Gene expression	Illumina HiSeq 2000	Department  of  Otolaryngology,  Xiangya  Hospital	SRP030673	SRS489190	329.16	1	489500886
SRX373515	Serum		Individuals with latent TB infection (XQA)		24586438	Identification of serum microRNA biomarkers for tuberculosis using RNA-seq.		sample XQA sequencing by Illumina GA II	human small RNA	Illumina Genome Analyzer II	IBP	SRP032650	SRS500418	212.87	1	298229470
SRX375141	Serum		Healthy BCG-inoculated individuals (XQB)	Normal	24586438	Identification of serum microRNA biomarkers for tuberculosis using RNA-seq.		sample XQB sequencing by Illumina GA II	human small RNA	Illumina Genome Analyzer II	IBP	SRP032650	SRS500419	225.81	1	316791265
SRX375142	Serum		Healthy un-inoculated individuals (XQC)	Normal	24586438	Identification of serum microRNA biomarkers for tuberculosis using RNA-seq.		sample XQC sequencing by Illumina GA II	human small RNA	Illumina Genome Analyzer II	IBP	SRP032650	SRS500420	228.35	1	321779710
SRX375143	Serum		Patients with active pulmonary tuberculosis (XQD)	Tuberculosis	24586438	Identification of serum microRNA biomarkers for tuberculosis using RNA-seq.		sample XQD sequencing by Illumina  GA II	human small RNA	Illumina Genome Analyzer II	IBP	SRP032650	SRS500421	207.17	1	292448625
SRX375448	Brain		ETMR1-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	ETMR1-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS499217	536.79	1	805098750
SRX375450	Brain		ETMR2-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	ETMR2-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS499241	473.92	1	711348800
SRX375452	Brain		ETMR2-R-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	ETMR2-R-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS499468	425.43	1	615158100
SRX375455	Brain		ETMR3-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Male	ETMR3-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500629	668.62	1	1020610750
SRX375461	Brain		ETMR3-R-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Male	ETMR3-R-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500655	473.86	1	724030850
SRX375462	Brain		ETMR4-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	ETMR4-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500656	649.18	1	1001310600
SRX375463	Brain		ETMR5-rna	Embryonal brain tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	ETMR5-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500658	594.32	1	871764500
SRX375464	Brain		PNET1-rna	Primitive neuroectodermal tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Male	PNET1-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500666	273.07	1	401754750
SRX375466	Brain		PNET2-rna	Primitive neuroectodermal tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Male	PNET2-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500667	506.71	1	767881500
SRX375467	Brain		PNET3-rna	Primitive neuroectodermal tumor	24316981	Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.	Female	PNET3-smRNA	ETMR exome	Illumina HiSeq 2000	McGill University	SRP032767	SRS500669	543.69	1	809574100
SRX386679	Blood		BGI-150p1		25074712	Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation.		China_type_2_diebetes_family	China_type_2_diebetes_family	Illumina Genome Analyzer II	BGI	SRP033491	SRS510685	542.59	1	853521298
SRX386680	Blood		BGI-150p2		25074712	Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation.		China_type_2_diebetes_family	China_type_2_diebetes_family	Illumina Genome Analyzer II	BGI	SRP033491	SRS510686	599.45	1	948214435
SRX386681	Blood		BGI-Fam150		25074712	Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation.		China_type_2_diebetes_family	China_type_2_diebetes_family	Illumina Genome Analyzer II	BGI	SRP033491	SRS510687	491.47	1	771227464
SRX389528		A549	CRSV3_mock-0h-01					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513279	258.55	1	370703357
SRX389602		A549	CRSV3_mock-0h-02					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513352	357.15	1	509652081
SRX389609		A549	CRSV3_RSV-M3-18h-19					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513357	339.72	1	481089046
SRX389715		A549	CRSV3_RSV-M3-18h-20					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513457	396.51	1	559060758
SRX389727		A549	CRSV3_delNS1-2-M3-18h-21					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513468	430.6	1	609267772
SRX389728		A549	CRSV3_delNS1-2-M3-18h-22					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513469	702.26	1	997739565
SRX389732		A549	CRSV3_RSV-M0-1-18h-23					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513470	600.39	1	855407131
SRX389733		A549	CRSV3_RSV-M0-1-18h-24					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513471	229.5	1	329077772
SRX389736		A549	CRSV3_delNS1-2-M0-1-18h-25					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513473	317.34	1	449763432
SRX389739		A549	CRSV3_delNS1-2-M0-1-18h-26					RNA-seq of in vitro virus infections	Analysis of viral and host RNA populations in the context of in vitro paramyxovirus infection.	Illumina HiSeq 2000	UMIGS	SRP033647	SRS513474	510.86	1	722806208
SRX426123	Blood		hPBMCs exposed to E. coli DH5? (30 minutes)					Transcriptome analysis of E. coli exposed hPBMCs (30 minutes)	Homo sapiens Transcriptome or Gene expression	Illumina MiSeq	NAVAL MEDICAL RESEARCH CENTER	SRP034856	SRS523362	683.89	2	933105473
SRX426124	Blood		hPBMCs exposed to E. coli DH5? (60 minutes)					Transcriptome analysis of E. coli exposed hPBMCs (60 minutes)	Homo sapiens Transcriptome or Gene expression	Illumina MiSeq	NAVAL MEDICAL RESEARCH CENTER	SRP034856	SRS523362	485.24	2	857273776
SRX426125	Blood		hPBMCs exposed to E. coli DH5? (120 minutes)					Transcriptome analysis of E. coli exposed hPBMCs (120 minutes)	Homo sapiens Transcriptome or Gene expression	Illumina MiSeq	NAVAL MEDICAL RESEARCH CENTER	SRP034856	SRS523362	593.33	2	1042376600
SRX426475	Blood		hPBMCs exposed to F. tularensis Schu S4 (30, 60, and 120 min)					F. tularensis Schu S4 exposed hPBMCs for 30, 60, and 120 minutes	Homo sapiens Transcriptome or Gene expression	Illumina MiSeq	NAVAL MEDICAL RESEARCH CENTER	SRP035390	SRS530036	628.35	2	1029876624
SRX426478	Blood		hPBMCs exposed to F. tularensis Schu S4 (120 minutes)					F. tularensis Schu S4 exposed hPBMCs  (120 minutes)	Homo sapiens Transcriptome or Gene expression	Illumina MiSeq	NAVAL MEDICAL RESEARCH CENTER	SRP035390	SRS530036	351.59	2	614600109
SRX463338		BEAS-2B	Normal human bronchial epithelial immortalized cell line		24633241	Massively parallel functional annotation of 3' untranslated regions.	not determined	Small RNA sequencing in Beas-2B cells	Homo sapiensTranscriptome or Gene expression	Illumina HiSeq 2000	UCSF	SRP036462	SRS552083	326.33	1	563088042
SRX513283	Breast		Tumor serum	Breast cancer	24904649	Different miRNA expression profiles between human breast cancer tumors and serum.		GSM1365849: Tumor_serum; Homo sapiens; miRNA-Seq	GSE56614: Human miRNA exprssion profiling in breast cancer tumors and the serum	Illumina HiSeq 2500	GEO	SRP041033	SRS590232	5.04	1	5826341
SRX513284	Breast		Tumor tissue	Breast cancer	24904649	Different miRNA expression profiles between human breast cancer tumors and serum.		GSM1365850: Tumor_tissue; Homo sapiens; miRNA-Seq	GSE56614: Human miRNA exprssion profiling in breast cancer tumors and the serum	Illumina HiSeq 2500	GEO	SRP041033	SRS590233	3.42	1	3907949
SRX513285	Breast		Serum from healthy woman control	Normal	24904649	Different miRNA expression profiles between human breast cancer tumors and serum.		GSM1365851: Normal_serum; Homo sapiens; miRNA-Seq	GSE56614: Human miRNA exprssion profiling in breast cancer tumors and the serum	Illumina HiSeq 2500	GEO	SRP041033	SRS590234	4.02	1	4648949
SRX513286	Breast		Normal tissue	Normal	24904649	Different miRNA expression profiles between human breast cancer tumors and serum.		GSM1365852: Normal_tissue; Homo sapiens; miRNA-Seq	GSE56614: Human miRNA exprssion profiling in breast cancer tumors and the serum	Illumina HiSeq 2500	GEO	SRP041033	SRS590235	3.62	1	4101550
SRX514979	Semen		Biopsy-proven cancer	Prostate cancer	24859988	Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers.		GSM1366854: Biopsy-proven cancer; Homo sapiens; miRNA-Seq	GSE56686: Quantitation of microRNAs in seminal fluid from men with and without prostate cancer	Illumina HiSeq 2000	GEO	SRP041082	SRS591048	3361.39	1	5377296750
SRX514980	Semen		Control	Normal	24859988	Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers.		GSM1366855: No detectable cancer on biopsy; Homo sapiens; miRNA-Seq	GSE56686: Quantitation of microRNAs in seminal fluid from men with and without prostate cancer	Illumina HiSeq 2000	GEO	SRP041082	SRS591050	3258.93	1	5136743550
SRX518937		293T	Wild Type		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370372: 293T Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593430	550.58	1	919538850
SRX518938		293T	NoDice(2-20)		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370373: NoDice(2-20) Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593431	618.69	1	1036914700
SRX518939		293T	NoDice(4-25)		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370374: NoDice(4-25) Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593433	553.08	1	926744450
SRX518940		293T	NoDice(4-25) Mock		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370375: NoDice(4-25) Mock Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593432	783.76	1	1280326746
SRX518941		293T	NoDice(4-25) Human Dicer Rescue		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370376: NoDice(4-25) Human Dicer Rescue Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593434	1020.43	1	1698973608
SRX518942		293T	NoDice(4-25) Drosophila Dicer1 and Loqs-PB Rescue		24757167	Derivation and characterization of Dicer- and microRNA-deficient human cells.		GSM1370377: NoDice(4-25) Drosophila Dicer1 and Loqs-PB Rescue Total Small RNA; Homo sapiens; miRNA-Seq	GSE56836: Derivation and characterization of Dicer and microRNA deficient human cells	Illumina HiSeq 2000	GEO	SRP041231	SRS593435	937.28	1	1564540821
SRX528316	Sperm		Adult donor 1		24835570	Chromatin and transcription transitions of mammalian adult germline stem cells and spermatogenesis.		GSM1375214: Sperm_smallRNAseq_Donor1; Homo sapiens; miRNA-Seq	GSE57096: Analysis of the Epigenomic and Transcriptional Landscapes during mammalian spermatogenesis [sperm; RNA-seq]	Illumina Genome Analyzer II	GEO	SRP041494	SRS598161	764.81	2	1576742328
SRX528317	Sperm		Adult donor 2		24835570	Chromatin and transcription transitions of mammalian adult germline stem cells and spermatogenesis.		GSM1375215: Sperm_smallRNAseq_Donor2; Homo sapiens; miRNA-Seq	GSE57096: Analysis of the Epigenomic and Transcriptional Landscapes during mammalian spermatogenesis [sperm; RNA-seq]	Illumina Genome Analyzer II	GEO	SRP041494	SRS598162	1636.96	3	3059528472
SRX546009		SUP-T1	Mock treated Human CD4 T-Cells at 12 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388178: Mock treated Human CD4 T-Cells at 12 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609761	439.65	1	812719494
SRX546010		SUP-T1	Mock treated Human CD4 T-Cells at 12 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388179: Mock treated Human CD4 T-Cells at 12 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609763	316.31	1	584738514
SRX546011		SUP-T1	Mock treated Human CD4 T-Cells at 12 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388180: Mock treated Human CD4 T-Cells at 12 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609762	421.39	1	760275990
SRX546012		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 12 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388181: HIV infected and UV treated Human CD4 T-Cells at 12 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609764	487.93	1	907437006
SRX546013		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 12 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388182: HIV infected and UV treated Human CD4 T-Cells at 12 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609765	462.89	1	859767372
SRX546014		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 12 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388183: HIV infected and UV treated Human CD4 T-Cells at 12 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609766	435.15	1	818110638
SRX546015		SUP-T1	HIV infected Human CD4 T-Cells at 12 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388184: HIV infected Human CD4 T-Cells at 12 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609767	547.89	1	1026821394
SRX546016		SUP-T1	HIV infected Human CD4 T-Cells at 12 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388185: HIV infected Human CD4 T-Cells at 12 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609768	425.33	1	783610902
SRX546017		SUP-T1	HIV infected Human CD4 T-Cells at 12 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388186: HIV infected Human CD4 T-Cells at 12 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609769	636.92	1	1204922304
SRX546018		SUP-T1	Mock treated Human CD4 T-Cells at 24 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388187: Mock treated Human CD4 T-Cells at 24 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609770	668.46	1	1222842312
SRX546019		SUP-T1	Mock treated Human CD4 T-Cells at 24 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388188: Mock treated Human CD4 T-Cells at 24 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609771	353.22	1	642963960
SRX546020		SUP-T1	Mock treated Human CD4 T-Cells at 24 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388189: Mock treated Human CD4 T-Cells at 24 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609772	507.09	1	911661210
SRX546021		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 24 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388190: HIV infected and UV treated Human CD4 T-Cells at 24 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609773	538.75	1	980227008
SRX546022		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 24 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388191: HIV infected and UV treated Human CD4 T-Cells at 24 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609774	533.02	1	973145286
SRX546023		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 24 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388192: HIV infected and UV treated Human CD4 T-Cells at 24 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609775	474.37	1	890071794
SRX546024		SUP-T1	HIV infected Human CD4 T-Cells at 24 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388193: HIV infected Human CD4 T-Cells at 24 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609777	482.12	1	870089418
SRX546025		SUP-T1	HIV infected Human CD4 T-Cells at 24 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388194: HIV infected Human CD4 T-Cells at 24 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609776	550.08	1	974752758
SRX546026		SUP-T1	HIV infected Human CD4 T-Cells at 24 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388195: HIV infected Human CD4 T-Cells at 24 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609778	504.05	1	949074516
SRX546027		SUP-T1	Mock treated Human CD4 T-Cells at 5 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388196: Mock treated Human CD4 T-Cells at 5 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609779	498.48	1	846713520
SRX546028		SUP-T1	Mock treated Human CD4 T-Cells at 5 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388197: Mock treated Human CD4 T-Cells at 5 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609781	527.13	1	701536896
SRX546029		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 5 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388198: HIV infected and UV treated Human CD4 T-Cells at 5 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609780	404.11	1	680629230
SRX546030		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 5 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388199: HIV infected and UV treated Human CD4 T-Cells at 5 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609782	225.77	1	377328564
SRX546031		SUP-T1	HIV infected and UV treated Human CD4 T-Cells at 5 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388200: HIV infected and UV treated Human CD4 T-Cells at 5 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609783	220.81	1	371965068
SRX546032		SUP-T1	HIV infected Human CD4 T-Cells at 5 hours 1		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388201: HIV infected Human CD4 T-Cells at 5 hours 1; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609784	312.8	1	528994044
SRX546033		SUP-T1	HIV infected Human CD4 T-Cells at 5 hours 2		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388202: HIV infected Human CD4 T-Cells at 5 hours 2; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609785	284.87	1	480706434
SRX546034		SUP-T1	HIV infected Human CD4 T-Cells at 5 hours 3		23386435	Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.		GSM1388203: HIV infected Human CD4 T-Cells at 5 hours 3; Homo sapiens; miRNA-Seq	GSE57763: Next-Generation Sequencing of Small RNAs from HIV-Infected Cells Identifies Phased microRNA Expression Patterns and Candidate Novel microRNAs Differentially Expressed upon Infection	Illumina Genome Analyzer IIx	GEO	SRP042053	SRS609786	1067.26	1	1811723382
SRX556516		HEK-293	293 embryonic kidney cell line		24464996	Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.		GSM1401413: 293 Total Small RNA; Homo sapiens; miRNA-Seq	GSE58127: Differential RISC association of endogenous human microRNAs predicts their inhibitory potential	Illumina HiSeq 2000	GEO	SRP042599	SRS623521	1114.74	1	1876312400
SRX556519		C8166	C8166 T-cell line		24464996	Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.		GSM1401416: C8166 Total Small RNA; Homo sapiens; miRNA-Seq	GSE58127: Differential RISC association of endogenous human microRNAs predicts their inhibitory potential	Illumina HiSeq 2000	GEO	SRP042599	SRS623524	502.46	1	851369800
SRX556521		A549	A549 alveolar basal epithelial cell line		24464996	Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.		GSM1401418: A549 Total Small RNA; Homo sapiens; miRNA-Seq	GSE58127: Differential RISC association of endogenous human microRNAs predicts their inhibitory potential	Illumina HiSeq 2000	GEO	SRP042599	SRS623526	722.95	1	1222023800
SRX556523		SH-SY5Y	SH-SY5Y neuroblastoma cell line		24464996	Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.		GSM1401420: SH-SY5Y Total Small RNA; Homo sapiens; miRNA-Seq	GSE58127: Differential RISC association of endogenous human microRNAs predicts their inhibitory potential	Illumina HiSeq 2000	GEO	SRP042599	SRS623528	484.66	1	905963650
SRX556525		LCL	LCL B-cell line		24464996	Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.		GSM1401422: LCL Total Small RNA; Homo sapiens; miRNA-Seq	GSE58127: Differential RISC association of endogenous human microRNAs predicts their inhibitory potential	Illumina HiSeq 2000	GEO	SRP042599	SRS623530	1078.05	1	1803879200
SRX666569		TZM-bl	Uninfected Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462561: TZM-bl Uninfected Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671259	543.9	1	951966400
SRX666570		TZM-bl	BaL Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462562: TZM-bl BaL Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671260	398.04	1	691487600
SRX666573		C8166	Uninfected Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462565: C8166 Uninfected Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671263	550.92	1	893241950
SRX666574		C8166	NL4-3 Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462566: C8166 NL4-3 Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671264	747.16	1	1207195100
SRX666575	Blood		CD4+ uninfected Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462567: CD4+ Uninfected Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671265	724.72	1	1126078100
SRX666576	Blood		CD4+ BaL Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462568: CD4+ BaL Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671266	583.78	1	923725950
SRX666577	Blood		CD4+ NL4-3 Day 3		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462569: CD4+ NL4-3 Day 3 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671267	600.72	1	951973200
SRX666578	Blood		Macrophage uninfected Day 5		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462570: Macrophage Uninfected Day 5 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671268	641.72	1	1305661950
SRX666579	Blood		Macrophage ADA Day 27		23592263	In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.		GSM1462571: Macrophage ADA Day 27 Small RNA Deep Sequencing; Homo sapiens; miRNA-Seq	GSE59944: In depth analysis of the interaction of HIV 1 with cellular microRNA biogenesis and effector mechanisms	Illumina HiSeq 2000	GEO	SRP045111	SRS671269	474.19	1	809069800
